CFL1 and hepatocellular carcinoma: Silencing of CFL1 can inhibit the growth viability, invasiveness, and epithelial-mesenchymal transition (EMT) of HCC cells in vitro, and it can also suppress the growth and lung metastasis of HCC cells in nude mice in vivo (39).